COMPLEMENT-DEPENDENT CYTOTOXICITY AGAINST HEPATOMA CELLS MEDIATED BY IGM ANTIBODIES IN SERUM FROM TUMOR-BEARING RATS.LANDO P; BLOMBERG F; RAFTELL M et al.1977; SCAND. J. IMMUNOL.; NORW.; DA. 1977; VOL. 6; NO 11; PP. 1081-1092; BIBL. 23 REF.Article

ARYLAMIDASES OF RAT LIVER AND CHEMICALLY INDUCED HEPATOMAS. I. SUBCELLULAR DISTRIBUTION OF L-LEUCINE 2-NAPHTHYLAMIDASE-ACTIVE ANTIGENS.BERZINS K; LANDO P; RAFTELL M et al.1977; BIOPHYS. BIOPHYS. ACTA; PAYS-BAS; DA. 1977; VOL. 497; NO 2; PP. 337-348; BIBL. 27 REF.Article

TUMOUR-ASSOCIATED ANTIGENS REACTING WITH CYTOTOXIC ANTIBODIES IN SERUM OF HEPATOMA-BEARING RATSLANDO P; NERZINS K; GABRIEL J et al.1981; BR. J. CANCER; ISSN 0007-0920; GBR; DA. 1981; VOL. 44; NO 4; PP. 522-531; BIBL. 25 REF.Article

ARYLAMIDASES OF RAT LIVER AND CHEMICALLY INDUCED HEPATOMAS. II. PREPARATION AND CHARACTERIZATION OF MONOSPECIFIC ANTISERA AGAINST TWO DISTINCT ARYLAMIDASE-ACTIVE-ANTIGENS.BERZINS K; LANDO P; RAFTELL M et al.1977; BIOCHIM. BIOPHYS. ACTA; PAYS-BAS; DA. 1977; VOL. 481; NO 2; PP. 586-593; BIBL. 24 REF.Article

DETERMINATION OF THE IMMUNOGLOBULIN CLASS OF COMPLEMENT-DEPENDENT CYTOTOXIC ANTIBODIES IN SERUM OF D23 HEPATOMA-BEARING RATSLANDO P; GABRIEL J; BERZINS K et al.1980; SCAND. J. IMMUNOL.; NOR; DA. 1980; VOL. 11; NO 3; PP. 253-260; BIBL. 20 REF.Article

Lymphoid procoagulant response to bacterial endotoxin in the ratLANDO, P. A; EDGINGTON, T. S.Infection and immunity. 1985, Vol 50, Num 3, pp 660-666, issn 0019-9567Article

An innate host response to the neoplastic cell: syngeneic rat tumor cells can elicit a rapid de novo lymphoid procoagulant responseLANDO, P. A; EDGINGTON, T. S.The Journal of immunology (1950). 1985, Vol 135, Num 5, pp 3587-3595, issn 0022-1767Article

Staphylococcal enterotoxin-dependent cell-mediated cytotoxicityKALLAND, T; HEDLUND, G; DOHLSTEN, M et al.Current Topics in Microbiology and Immunology. 1991, Vol 174, pp 81-92, issn 0070-217XArticle

Staphylococcal enterotoxins direct and trigger CTL killing of autologous HLA-DR⁺ mononuclear leukocytes and freshly prepared leukemia cellsHEDLUND, G; DOHLSTEN, M; LANDO, P. A et al.Cellular immunology (Print). 1990, Vol 129, Num 2, pp 426-434, issn 0008-8749, 9 p.Article

Amidolytic assay for procoagulant activity of lymphoid and tumor cellsLANDO, P. A; BIAZAK, C. E; EDGINGTON, T. S et al.Journal of immunological methods. 1986, Vol 89, Num 1, pp 131-139, issn 0022-1759Article

Tumor-reactive superantigens suppress tumor growth in humanized scid miceLANDO, P. A; DOHLSTEN, M; OHLSSON, L et al.International journal of cancer. 1995, Vol 62, Num 4, pp 466-471, issn 0020-7136Article

T cell killing of human colon carcinomas by monoclonal-antibody-targeted superantigensLANDO, P. A; DOHLSTEN, M; HEDLUND, G et al.Cancer immunology and immunotherapy. 1993, Vol 36, Num 4, pp 223-228, issn 0340-7004Article

Targeting of human cytotoxic T lymphocytes to MHC class II-expressing cells by staphylococcal enterotoxinsDOHLSTEN, M; LANDO, P. A; HEDLUNG, G et al.Immunology (Oxford). 1990, Vol 71, Num 1, pp 96-100, issn 0019-2805, 5 p.Article

Monoclonal antibody-targeted superantigens : a different class of anti-tumor agentsDOHLSTEN, M; HEDLUNG, G; AKERBLOM, E et al.Proceedings of the National Academy of Sciences of the United States of America. 1991, Vol 88, Num 20, pp 9287-9291, issn 0027-8424Article

The TcR-CD3 complex is required for activation of human lymphocytes with staphylococcal enterotoxin ALANDO, P. A; DOHLSTEN, M; KALLAND, T et al.Scandinavian journal of immunology (Print). 1990, Vol 31, Num 2, pp 133-138, issn 0300-9475Article

Therapy of human non-small-cell lung carcinoma using antibody targeting of a modified superantigenFORSBERG, G; OHLSSON, L; BRODIN, T et al.British journal of cancer. 2001, Vol 85, Num 1, pp 129-136, issn 0007-0920Article

Preparation and characterization of conjugates of monoclonal antibodies and spathylococcal enterotoxin A using a new hydrophilic cross-linkerAKERBLOM, E; DOHLSTEN, M; BRYNÖ, C et al.Bioconjugate chemistry. 1993, Vol 4, Num 6, pp 455-466, issn 1043-1802Article

Genetically engineered superantigens in experimental tumor therapyANTONSSON, P; HANSSON, J; KALLAND, T et al.Springer seminars in immunopathology. 1996, Vol 17, Num 4, pp 397-410, issn 0344-4325Article

Human major histocompatibility complex class II-negative colon carcinoma cells present staphylococcal superantigens to cytotoxic T lymphocytes : evidence for a novel enterotoxin receptorDOHLSTEN, M; HEDLUND, G; SEGREN, S et al.European journal of immunology. 1991, Vol 21, Num 5, pp 1229-1233, issn 0014-2980, 5 p.Article

Role of the adhesion molecule ICAM-1 (CD54) in staphylococcal enterotoxin-mediated cytotoxicityDOHLSTEN, M; HEDLUND, G; LANDO, P. A et al.European journal of immunology. 1991, Vol 21, Num 1, pp 131-135, issn 0014-2980Article

Immunotherapy of human colon cancer by antibody-targeted superantigensDOHLSTEN, M; LANDO, P. A; BJÖRK, P et al.Cancer immunology and immunotherapy. 1995, Vol 41, Num 3, pp 162-168, issn 0340-7004Article

A recombinant c-terminal fragment of staphylococcal enterotoxin a binds to human MHC class II products but does not activate T cellsHEDLUNG, G; DOHLSTEN, M; HERRMANN, T et al.The Journal of immunology (1950). 1991, Vol 147, Num 12, pp 4082-4085, issn 0022-1767Article